Millions of doses of Pfizer's Paxlovid will go to waste in UK, EU as COVID demand plummets

On the heels of a major Paxlovid inventory write-off in the United States, many more doses of Pfizer's COVID-fighting antiviral are going to waste overseas.

By the end of February, the value of leftover courses headed for the bin will reach $2.2 billion in Europe, according to London-based life sciences analytics firm Airfinity.